Cargando…

Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy

BACKGROUND: To analyze the clinical and dosimetric risk factors of acute esophagitis (AE) in non-small-cell lung cancer (NSCLC) patients treated with concomitant chemoradiotherapy. METHODS: Seventy-six NSCLC patients treated with concomitant chemoradiotherapy were retrospectively analyzed. Forty-one...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, ZiCheng, Xu, Jin, Zhou, Tao, Yi, Yan, Li, HongSheng, Sun, HongFu, Huang, Wei, Wang, DongQing, Li, BaoSheng, Ying, GuoGuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937013/ https://www.ncbi.nlm.nih.gov/pubmed/24528546 http://dx.doi.org/10.1186/1748-717X-9-54

Ejemplares similares

Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up
por: Liu, Ming, et al.
Publicado: (2017)

Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy
por: Wang, Qian, et al.
Publicado: (2021)

The Key Clinical Questions of Neoadjuvant Chemoradiotherapy for Resectable Esophageal Cancer—A Review
por: Han, Dan, et al.
Publicado: (2022)

Metastasis of esophageal small cell carcinoma to the appendix: A case report and literature review
por: Wang, Qianrong, et al.
Publicado: (2017)

Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
por: Yang, Yang, et al.
Publicado: (2020)

Genetic Variants in MTHFR Gene Predict ≥ 2 Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Patients Treated with Thoracic Radiotherapy
por: Zhang, Yang, et al.
Publicado: (2017)

Functional dosimetric metrics for predicting radiation-induced lung injury in non-small cell lung cancer patients treated with chemoradiotherapy
por: Wang, Dongqing, et al.
Publicado: (2012)

Prognostic significance of lung radiation dose in patients with esophageal cancer treated with neoadjuvant chemoradiotherapy
por: Lin, Jhen-Bin, et al.
Publicado: (2019)

Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study
por: Liu, Chengxin, et al.
Publicado: (2023)

A new risk score model based on lactate dehydrogenase for predicting prognosis in esophageal squamous cell carcinoma treated with chemoradiotherapy
por: Liu, Chengxin, et al.
Publicado: (2023)

Relationship between (18)F-fluorodeoxyglucose uptake in primary lesions and clinicopathological characteristics of esophageal squamous cell carcinoma patients
por: SUN, MINGPING, et al.
Publicado: (2013)

Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
por: Zhu, Shan, et al.
Publicado: (2016)

Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study
por: Wang, Dongqing, et al.
Publicado: (2013)

The CONUT score is prognostic in esophageal cancer treated with chemoradiotherapy
por: Demir, Metin, et al.
Publicado: (2022)

Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy
por: Deng, Yuxia, et al.
Publicado: (2017)

Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy
por: Qiu, Jianjian, et al.
Publicado: (2022)

Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy
por: Dang, Jun, et al.
Publicado: (2014)

Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
por: Pai, Chu-Pin, et al.
Publicado: (2022)

Integrated cohort of esophageal squamous cell cancer reveals genomic features underlying clinical characteristics
por: Li, Minghao, et al.
Publicado: (2022)

TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell Carcinoma
por: Liu, ShiLiang, et al.
Publicado: (2017)

Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer
por: Wu, Sheng-Xi, et al.
Publicado: (2017)

Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy
por: Shi, Yan-Jie, et al.
Publicado: (2022)

Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis
por: Wang, Dong-Bin, et al.
Publicado: (2016)

Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
por: Honma, Yoshitaka, et al.
Publicado: (2019)

Clinical Prognostic Factors for Patients With Esophageal Cancer Treated With Definitive Chemoradiotherapy
por: Favareto, Sergio L, et al.
Publicado: (2021)

Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer
por: Zhao, Qian, et al.
Publicado: (2016)

Response Prediction to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Using Delta-Radiomics Based on Sequential Whole-Tumor ADC Map
por: An, Dianzheng, et al.
Publicado: (2022)

Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancer
por: Han, Dan, et al.
Publicado: (2014)

A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer
por: Zhu, Li-Li, et al.
Publicado: (2015)

A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
por: Ding, Tianyan, et al.
Publicado: (2021)

Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy
por: Gennigens, Christine, et al.
Publicado: (2020)

A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer
por: Luo, He-San, et al.
Publicado: (2020)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
por: Chen, Mingqiu, et al.
Publicado: (2018)

Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010)

Dose-Dependent Radiation-Induced Myocardial Damage in Esophageal Cancer Treated With Chemoradiotherapy: A Prospective Cardiac Magnetic Resonance Imaging Study
por: Umezawa, Rei, et al.
Publicado: (2020)

Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
por: Noh, Jae Myoung, et al.
Publicado: (2016)

Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Sen, Fatma, et al.
Publicado: (2016)

The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: a nationwide Taiwanese cohort study
por: Lin, Shih-Min, et al.
Publicado: (2017)

Evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma: A single institution experience
por: Ke, Te-Min, et al.
Publicado: (2018)

Combined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapy
por: Miao, Chuanwang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6ecvj2rvlnimv69lipgqbf6e3p